Finance

Lists
Why is 1779 down 9.52%?
Dive Deeper
1779:HKG
LongBio Pharma (Suzhou) Co Ltd
HK$102.70
-9.52%
(-10.80) 1D
Sep 28, 4:08:26 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1779...
Open
HK$109.60
High
HK$113.10
Low
HK$100.60
Mkt. cap
7.84B
Avg. vol.
210.47K
Volume
76.80K
52-wk high
HK$165.90
52-wk low
HK$72.65
EPS
-HK$3.40
Shares outstanding
75.06M
No. of employees
94
Open
HK$109.60
High
HK$113.10
Low
HK$100.60
Mkt. cap
7.84B
Avg. vol.
210.47K
Volume
76.80K
52-wk high
HK$165.90
52-wk low
HK$72.65
EPS
-HK$3.40
Shares outstanding
75.06M
No. of employees
94
About LongBio Pharma (Suzhou) Co Ltd
CEO-
Employees94
Founded2020
Headquarters-
SectorBiotechnology
Websitelongbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
439.50K
-
1.70M
1.70M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
33.65M
30.26M
54.11M
54.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.67M
9.62M
12.40M
12.40M
Operating expense
39.40M
40.94M
68.78M
68.78M
Total operating expenses
39.40M
40.94M
68.78M
68.78M
Operating income
-38.96M
-40.94M
-67.08M
-67.08M
Other non operating income
-
-
-
-
EBT including unusual items
-47.10M
-38.01M
-67.40M
-67.40M
EBT excluding unusual items
-47.10M
-41.15M
-67.40M
-67.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
83.50K
1.07M
2.27M
2.27M
Net income
-47.10M
-38.01M
-67.40M
-67.40M
Net profit margin
-10,717.63%
-
-3,963.78%
-3,963.78%
Earnings per share
-
-
-
-
Interest and investment income
-
49.00K
-
-
Interest expense
-8.14M
-252.00K
-322.00K
-322.00K
Net interest expenses
-8.14M
-203.00K
-322.00K
-322.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-38.08M
-40.00M
-66.12M
-66.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps